Interestingly, it has been demonstrated that the classical IKK-β-dependent NFκB pathway may be the link to inflammation and cancer as activation results in upregulation of proinflammatory cytokines as well as several antiapoptotic factors [18]. Here, NFKB1 is linked to cancer.